Cargando…
Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
Primary cutaneous anaplastic large cell lymphoma (PCALCL) is a rare variant of cutaneous T cell lymphoma (CTCL) characterized by CD30-expressing large atypical cells with kidney-shaped nuclei called hallmark cells. Since PCALCL is a rare variant of CTCL, the treatment of PCALCL is still controversia...
Autores principales: | Amagai, Mayuko, Furudate, Sadanori, Ohuchi, Kentaro, Takahashi, Toshiya, Yamazaki, Emi, Chiba, Hiromu, Asano, Yoshihide, Fujimura, Taku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459557/ https://www.ncbi.nlm.nih.gov/pubmed/36157690 http://dx.doi.org/10.1159/000526312 |
Ejemplares similares
-
Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
por: Kaminetzky, David, et al.
Publicado: (2008) -
Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox
por: Lewis, Daniel J., et al.
Publicado: (2017) -
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma
por: Lansigan, Frederick, et al.
Publicado: (2010) -
Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox
por: Cervigón-González, Iván, et al.
Publicado: (2011) -
Denileukin Diftitox in Combination with Rituximab for Previously Untreated Follicular B-cell Non-Hodgkin’s Lymphoma
por: Ansell, Stephen M., et al.
Publicado: (2011)